Tag: Vaccines
Global Childhood Vaccination Rates Still Haven’t Recovered from Pandemic Declines
By Robin Foster HealthDay Reporter
MONDAY, July 15, 2024 (HealthDay News) -- More than four years after the pandemic began, childhood vaccination rates worldwide have...
Prenatal Vaccination With RSV Prefusion F Does Not Increase Risk for Preterm Birth
After adjustment for potential confounders, addressing immortal time bias, prenatal vaccination not linked to increased risk for PTB
First-Trimester COVID-19 Vaccine Does Not Increase Risk for Birth Defects
Receipt of mRNA COVID-19 vaccine during the first trimester not associated with an increased risk for selected major structural birth defects
Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms
Reduction in prevalence of parent-reported child asthma symptoms seen with increase in COVID-19 vaccination coverage
U.S. Government to Pay Moderna $176 Million to Develop mRNA Flu Vaccine
By Robin Foster HealthDay Reporter
TUESDAY, July 2, 2024 (HealthDay News) -- U.S. health officials announced Tuesday that the federal government will pay Moderna $176...
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of Age
By Robin Foster HealthDay Reporter
FRIDAY, June 28, 2024 (HealthDay News) -- As a summer wave of COVID infections rolls across the country, U.S. health...
CDC Strengthens RSV Vaccine Advice for Those Over 75
By Robin Foster HealthDay Reporter
THURSDAY, June 27, 2024 (HealthDay News) -- In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all...
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
Findings for range of neonatal outcomes among individuals receiving vaccine during pregnancy
Summer COVID Cases Are Rising Across America
By Robin Foster HealthDay Reporter
TUESDAY, June 25, 2024 (HealthDay News) -- As scorching summer temperatures drive Americans indoors and millions travel for vacations and...
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
Company says vaccine covers serotypes responsible for approximately 84 percent of invasive pneumococcal disease in adults ages 50 years and older
